COMPASS PATHWAYS PLC Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- COMPASS PATHWAYS PLC stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $1.13M, a 12422.22% increase year-over-year.
- COMPASS PATHWAYS PLC stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $24.00K, a 1100.00% increase year-over-year.
- COMPASS PATHWAYS PLC stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $9.00K.
- COMPASS PATHWAYS PLC stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $2.00K, a 99.09% decline year-over-year.
- COMPASS PATHWAYS PLC stock issued during period, value, stock options exercised for fiscal 2025 was $35.00K, a 84.16% decline from fiscal 2024.
- COMPASS PATHWAYS PLC stock issued during period, value, stock options exercised for fiscal 2024 was $221.00K, a 10950.00% increase from fiscal 2023.
- COMPASS PATHWAYS PLC stock issued during period, value, stock options exercised for fiscal 2023 was $2.00K, a 99.50% decline from fiscal 2022.
- COMPASS PATHWAYS PLC stock issued during period, value, stock options exercised for fiscal 2022 was $401.00K, a 78.95% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $1.13M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $24.00K 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $35.00K 10-K · filed 2026-03-24 | |
| 2025-06-30 | $9.00K 10-Q · filed 2026-08-05 | |
| 2025-03-31 | $2.00K 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $221.00K 10-K · filed 2026-03-24 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-07-31 | |
| 2024-03-31 | $220.00K 10-Q · filed 2025-11-04 | |
| 2023-12-31 | $2.00K 10-K · filed 2025-02-27 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-10-31 | |
| 2023-06-30 | $1.00K 10-Q · filed 2024-10-31 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-10-31 | |
| 2022-12-31 | $401.00K 10-K · filed 2024-02-29 | |
| 2022-06-30 | $4.00K 10-Q · filed 2023-11-02 | |
| 2022-03-31 | $397.00K 10-Q · filed 2023-11-02 | |
| 2021-12-31 | $1.91M 10-K · filed 2024-02-29 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $47.00K 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $998.00K 10-Q · filed 2022-05-10 | |
| 2020-12-31 | $0.00 10-K · filed 2023-02-28 | |
| 2020-09-30 | $0.00 6-K · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |